Shortly after, GRP78 antibodies were also discovered to impair the BBB in patients with paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome (PCD-LEMS), thereby potentially allowing access of pathogenic autoantibodies (Shimizu et al., 2019). Here, HSPA5 is linked to Lambert-Eaton myasthenic syndrome.